CAN
AGN

Claraphi Advisory Network’s Allergan plc AGN Stock Holding History

Claraphi Advisory Network’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,852
Closed -$505K – 1330
2020
Q1 		$505K Buy
+2,852
New +$537K 0.24% 83
2018
Q2 		– Sell
-1,784
Closed -$301K – 292
2018
Q1 		$301K Buy
+1,784
New +$299K 0.21% 140

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Claraphi Advisory Network's AGN Position: Q2 2020 in Review

Claraphi Advisory Network sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,852 shares — an estimated $505K sold.

Claraphi Advisory Network first reported a position in AGN in Q1 2018 and held it in 2 quarters. The position peaked at $505K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Claraphi Advisory Network reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Claraphi Advisory Network sold 2,852 Allergan plc shares in Q2 2020, an estimated $505K.
  • Claraphi Advisory Network first reported a position in Allergan plc in Q1 2018 and held it in 2 quarters.
  • Claraphi Advisory Network's Allergan plc position peaked at $505K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Claraphi Advisory Network's 13F filing for Q2 2020, filed 14 Aug 2020.